Biodel Inc (NASDAQ:BIOD)

Data as of 12:50pm ET
 -0.01 / -0.65%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Biodel, Inc. is a specialty pharmaceutical company that develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. It is developing novel forms of insulin and other peptide hormones for use in treating diabetes and its complications, including hyperglycemia, hypoglycemia, cardiovascular complications and weight control. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT.

Contact Information

Biodel, Inc.
100 Saw Mill Road
Danbury Connecticut 06810
P:(203) 796-5000
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Errol B. De SouzaPresident, Chief Executive Officer & Director
Erik SteinerVice President-Operations
Gary G. GemignaniChief Financial Officer
Alan Seth KrasnerChief Medical Officer
Paul S. BavierSecretary & Chief Compliance Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.